Recomienda este artículo a tus amigos:
Intracellular Delivery III: Market Entry Barriers of Nanomedicines - Fundamental Biomedical Technologies 1st ed. 2017 edition
Intracellular Delivery III: Market Entry Barriers of Nanomedicines - Fundamental Biomedical Technologies
It can be argued that drugs generated using the conventional means of drug development (i.e., relying on facile biodistribution and activity after (preferably) oral administration) are not suitable for a target-specific delivery and would not benefit from such delivery even when a seemingly perfect delivery system is available.
453 pages, 16 black & white illustrations, 65 colour illustrations, biography
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 23 de diciembre de 2016 |
| ISBN13 | 9783319435237 |
| Editores | Springer International Publishing AG |
| Páginas | 453 |
| Dimensiones | 155 × 235 × 29 mm · 1,02 kg |
| Lengua | Alemán |
| Editor | Prokop, Ales |
| Editor | Weissig, Volkmar |